Management of acute cancer treatment-induced diarrhea
- PMID: 14702928
- DOI: 10.1053/j.soncn.2003.09.009
Management of acute cancer treatment-induced diarrhea
Abstract
Objectives: To describe the dietary and pharmacologic management of acute CTID.
Data sources: Primary and secondary literature, and clinical experience.
Conclusion: When dietary strategies do not work, or when patients present with grade 3/4 diarrhea, pharmacologic intervention is required. First-line therapy should be initiated quickly with loperamide or diphenoxylate/atropine in recommended doses. Somatostatin analogues are effective as second-line therapy or as first-line therapy for patients with grade 3/4 diarrhea.
Implications for nursing practice: Oncology nurses should strive to match treatment with the severity of symptoms of CTID. Whatever therapy is chosen, the goal must be to quickly control this debilitating and potentially life-threatening side effect so that primary chemotherapy and/or radiation therapy may be resumed and completed.
Similar articles
-
Overview of chemotherapy-induced diarrhea.Semin Oncol Nurs. 2003 Nov;19(4 Suppl 3):2-5. doi: 10.1053/j.soncn.2003.09.007. Semin Oncol Nurs. 2003. PMID: 14702926 Review.
-
New strategies for the prevention and reduction of cancer treatment-induced diarrhea.Semin Oncol Nurs. 2003 Nov;19(4 Suppl 3):17-21. doi: 10.1053/j.soncn.2003.09.010. Semin Oncol Nurs. 2003. PMID: 14702929 Review.
-
High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients.Support Care Cancer. 2000 Jan;8(1):65-7. doi: 10.1007/s005209900085. Support Care Cancer. 2000. PMID: 10650901 Clinical Trial.
-
Antimotility agents for the treatment of acute noninfectious diarrhea in critically ill patients: A practice management guideline from the Eastern Association for the Surgery of Trauma.J Trauma Acute Care Surg. 2019 Oct;87(4):915-921. doi: 10.1097/TA.0000000000002449. J Trauma Acute Care Surg. 2019. PMID: 31574060
-
Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.Am J Hematol. 1995 Nov;50(3):167-72. doi: 10.1002/ajh.2830500304. Am J Hematol. 1995. PMID: 7485077 Clinical Trial.
Cited by
-
Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management.Ann Gastroenterol. 2012;25(2):106-118. Ann Gastroenterol. 2012. PMID: 24713845 Free PMC article. Review.
-
The pharmacologic treatment of short bowel syndrome: new tricks and novel agents.Curr Gastroenterol Rep. 2014;16(7):392. doi: 10.1007/s11894-014-0392-2. Curr Gastroenterol Rep. 2014. PMID: 25052938 Review.
-
Chimonanthus nitens var. salicifolius Aqueous Extract Protects against 5-Fluorouracil Induced Gastrointestinal Mucositis in a Mouse Model.Evid Based Complement Alternat Med. 2013;2013:789263. doi: 10.1155/2013/789263. Epub 2013 Dec 3. Evid Based Complement Alternat Med. 2013. PMID: 24367389 Free PMC article.
-
Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies.Support Care Cancer. 2006 Sep;14(9):890-900. doi: 10.1007/s00520-006-0040-y. Epub 2006 Apr 8. Support Care Cancer. 2006. PMID: 16604351 Review.
-
Transition-Metal-Free C-Diarylations to Reach All-Carbon Quaternary Centers.JACS Au. 2024 Aug 5;4(8):2832-2837. doi: 10.1021/jacsau.4c00500. eCollection 2024 Aug 26. JACS Au. 2024. PMID: 39211612 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical